Controlled Nutrient Delivery to Pancreatic Islets Using Polydopamine-Coated Mesoporous Silica Nanoparticles

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Nanotechnology

Background:

• Transplanted pancreatic islets require sustained nutrient support for survival and function.
• Inflammatory conditions can compromise islet viability post-transplantation.
• Mesoporous silica nanoparticles (MSNPs) offer a versatile platform for drug and nutrient delivery.

Purpose of the Study:

• To design and optimize a nanoscale platform for sustained glutamine delivery to pancreatic islets.
• To evaluate the efficacy of the platform in supporting islet viability and function ex vivo and in vivo.

Main Methods:

• Fabrication of polydopamine (PD)-coated MSNPs loaded with glutamine (G).
• Optimization of PD concentration and incubation time for controlled G release.
• Ex vivo assessment of islet viability and function under inflammatory conditions.
• In vivo evaluation of islet engraftment and glycemic control in STZ-diabetic mice.

Main Results:

• Optimized PD-G-MSNPs (0.5 mg/mL PD, 0.5 h incubation) demonstrated superior support for islet viability and function ex vivo, especially under inflammation.
• In vivo studies showed that PD-G-MSNPs significantly improved islet engraftment and function compared to G alone.
• Mice treated with PD-G-MSNPs maintained glycemic control for 30 days post-transplantation.

Conclusions:

• The developed PD-G-MSNP nanoscale platform enables sustained glutamine delivery, crucial for supporting transplanted islets.
• This platform holds promise for enhancing islet transplantation success by providing essential nutrients until vascularization occurs.